{"id":"W3174342652","doi":"10.1002/ajh.26276","title":"Clinical outcomes after 4.5 years of eliglustat therapy for <scp>Gaucher</scp> disease type 1: Phase 3 <scp>ENGAGE</scp> trial final results","year":2021,"lang":"en","type":"article","venue":"American Journal of Hematology","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"National Center for Advancing Translational Sciences; Sanofi Genzyme; Sanofi","keywords":"Medicine; Adverse effect; Placebo; Concomitant; Internal medicine; Gastroenterology; Clinical endpoint; Enzyme replacement therapy; Disease; Clinical trial; Pathological; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004407468,0.001091277,0.002251398,0.0003440067,0.000727671,0.001161279,0.0006667941,0.001669878,0.003151895],"category_scores_gemma":[0.002517987,0.0002815779,0.002556403,0.0003961924,0.0006919546,0.001163974,0.0005461072,0.002821225,0.0007879452],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008860573,"about_ca_system_score_gemma":0.0009754061,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001320749,"about_ca_topic_score_gemma":0.00163426,"domain_scores_codex":[0.9989065,0.0003997643,0.00009621846,0.0001193848,0.0001837615,0.0002944127],"domain_scores_gemma":[0.9969959,0.0004571445,0.0009415617,0.0002170962,0.0004478696,0.0009404955],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8303769,0.02129925,0.05383134,0.0007880318,0.003533038,0.000465669,0.0003126463,0.003436701,0.01141644,0.0002448801,0.01176773,0.0625274],"study_design_scores_gemma":[0.1707502,0.548436,0.2620552,0.0001562664,0.003592917,0.0008323134,0.0002463471,0.00217557,0.004882921,0.0005620993,0.006162154,0.0001479988],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9882318,0.002563698,0.0004246136,0.0004227965,0.0001266225,0.0009066236,0.00378128,0.00007608374,0.003466303],"genre_scores_gemma":[0.9862745,0.0005628303,0.0004229693,0.0007789927,0.0001521319,0.001205569,0.008183585,0.00001858301,0.00240069],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004407468,"threshold_uncertainty_score":0.02330917,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06823739378827903,"score_gpt":0.4201139288326081,"score_spread":0.3518765350443291,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}